Corbus Pharmaceuticals Holdings (CRBP) Other Non Operating Income (2013 - 2025)

Corbus Pharmaceuticals Holdings' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$50000.0 for Q3 2025.

• In Q3 2025, Other Non Operating Income fell 125.0% year-over-year to -$50000.0; the TTM figure through Sep 2025 stood at $2.5 million (down 47.63% YoY), while the FY2024 annual figure was $4.1 million, up 51.08% from the prior year.
• Other Non Operating Income was -$50000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, down from $176000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $12.3 million in Q4 2021 to a low of -$208683.0 in Q2 2022.
• Historically, Other Non Operating Income has averaged $1.1 million across 5 years, with a median of $179500.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income slumped 1564.4% in 2022, then surged 348114.29% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at $12.3 million in 2021, then slumped by 98.49% to $186330.0 in 2022, then surged by 1008.79% to $2.1 million in 2023, then plunged by 37.32% to $1.3 million in 2024, then slumped by 103.86% to -$50000.0 in 2025.
• The last three Other Non Operating Income figures came in at -$50000.0 (Q3 2025), $176000.0 (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.